Aberrations of the p53 gene in 27 solar keratoses were examined by the polymerase chain reaction and single-strand conformation polymorphism and DNA sequencing analyses. In a series of Japanese patients, eight of27 cases (30%) of solar keratosis showed structural abnormalities of the p53 gene. Six of eight aberrations of p53 gene were determined to be single nucleotide substitutions, and five of these were located at a dipyrimidine site. In solar keratosis, noticeable mutations were C to T in three cases, and one each of C M utations in the p53 gene from squamous cell carcinoma (SCe) and basal cell carcinoma (BCe) were reported by Brash et ai, Pierceal et ai, and Moles et al [1] [2] [3] in addition to mutations in the Ha-ras, Ki-ras and N-ras genes [1,2,4]. The majority of C to T transitions occurred at dipyrirnidine sites, and especially a double-base change, such as CC to TT, is considered to be specific to ultraviolet (UV) light [5] [6] [7] [8] . SCC may develop from solar keratosis (SK), which is a result of long-term exposure to su nlight.
Aberrations of the p53 gene in 27 solar keratoses were examined by the polymerase chain reaction and single-strand conformation polymorphism and DNA sequencing analyses. In a series of Japanese patients, eight of27 cases (30%) of solar keratosis showed structural abnormalities of the p53 gene. Six of eight aberrations of p53 gene were determined to be single nucleotide substitutions, and five of these were located at a dipyrimidine site. In solar keratosis, noticeable mutations were C to T in three cases, and one each of C M utations in the p53 gene from squamous cell carcinoma (SCe) and basal cell carcinoma (BCe) were reported by Brash et ai, Pierceal et ai, and Moles et al [1] [2] [3] in addition to mutations in the Ha-ras, Ki-ras and N-ras genes [1, 2, 4] . The majority of C to T transitions occurred at dipyrirnidine sites, and especially a double-base change, such as CC to TT, is considered to be specific to ultraviolet (UV) light [5] [6] [7] [8] . SCC may develop from solar keratosis (SK), which is a result of long-term exposure to su nlight.
The abnormal accumulation of p53 protein was found by the immunohistochemical staining with antibody to p53 protein in the nuclei of SK [9 -11] . Immunohistochemical detection of p53 protein, however, may not indicate the presence of p53 gene mutations [4) . To clarify the presence of p53 gene alteration in SK, we used a combination of the polymerase chain reaction and single-strand conformation polymorphism (PCR-SSCP) analysis [12] and direct DNA sequencing analysis. A correlation between alteration of the p53 gene and accumulation of p53 protein was also analyzed.
MATERIALS AND METHODS
Sample Fresh specimens of 27 SK were excised from 25 patients between June 1991 and December 1992 under th e collaboration of Department of Dermatology of the N ational Cancer Center Hospital; Saitama Medical School; School of Medicine, Yokohama City University; School of Medicine, Kyushu University; and the School of Medicine, Kagoshima University. Surgical specimens were either fixed with the AMeX (acetone-methyl benzoate-xylene and paraffin embedding) method [13] of embedded in OCT compound (TISSUE-TEK, Miles) to perfonn tissue sections, and were subsequently se nt to the Epidemiology Division, National Cancer Center Manuscript received February 4,1994 ; accepted for publication May 13, 1994 .
Reprint requests to: Dr. Masahito Taguchi, Epidemiology Division, N ational Cancer Center Research Institute, 1-1, Tsukiji, 5-chome, Chuo-ku, Tokyo 104, Japan.
Abbreviations: AMeX, acetone-methyl benzoate-xylene and paraffin embedding; PCR-SSCP, polymerase chain reaction and single-strand conformation polymorphism; SK, solar keratosis.
to A and T to C nucleotide changes. p53 protein was detected immunohistochemically in the nuclei of six of27 cases (22%) of solar keratosis. Nuclear staining for p53 protein was only significantly correlated with the presence of missense mutation of p53 gene (p < 0.01).
Aberrations of the p53 gene in solar keratosis may be a marker to predict early cancerous lesions. Research Institute, and stored at -BO ·C until use. Genomic DNA extractions were performed on AMeX sections and frozen sections (50}lm in thickness) using the proteinase K-phenol-chloroform extraction method as described by Goelz et al [14] . Five normal parts of the biopsied skin with SK and five skin tissues from the non-sun-exposed areas were used for control specimens.
PCR-SSCP Analysis DNA samples (0.1 }lg) were subjected to a polymerase chain reaction (PCR) using two appropriate oligonucleotides as primers [15] . The oligonucleotide primers for PCR amplification of all p53 exons (exon 2 to 11) were designed as described previously [16] . The PCR was carried out in 17 }ll solution containing 1.25 mM dA TP, 1.25 mM dGTP, 1.25 mM dCTP, 1.25 mM dTTP, 0.75-1.0 mM MgCI2' 10}lM primers, 0.1 }lg of sample DNA, 0.2}l1 of [a_ 32 p] dCTP (3000 }lCi/mmol, 10 mCi/}lI, Amersham), 0.5 unit ofTaq DNA polymerase (Perkin-Elmer Cetus, Norwalk, CAl in 10 mM Tris-HCI, pH B.3, containing 0.1 % gelatin, and 12}l1 mineral oil. The samples were subjected to 30 cycles at 94·C for 30 seconds, 55·C for 30 seconds, and 72 ·C for 60 seconds, on a DNA thennal cycler (Perkin-Elmer Cetus). On another occasion, the 5' -ends of these primers were labeled by the polynucleotide kinase reaction with [y_32P]A TP as described previously [17] .
The PCR mixture (5 }ll) was heated at BO·C with 45}l1 offormamide dye mixture (95% formamide dye, 20 mM ethylenediaminetetraacetic acid, 0.05% xylene cyanol, 0.05% bromphenol blue), and then 1 }ll of the preparation was applied to 5% polyacrylamide gel containing 45 mM Tris-borate (PH B.3) and 4 mM ethylenediaminetetraacetic acid. Glycerol (5%) was added for better separation of bands. Electrophoresis was perfonned at 30 W for 2 to 4 h with cooling by a fan. The gel was dried on filter paper and exposed to X-ray film at -80·C for 4 to 12 h using an intensifying screen. The PCR-SSCP analysis was repeated 2-4 times to confirm the same mobility shift pattern.
Direct DNA Sequencing DNA fragments showing repeatedly the same mobility shift pattern by PCR-SSCP analysis were eluted from polyacrylamide gel as described previously [18] , and were amplified by 30 cycles of the symmetric PCR under the same conditions as described earlier. The reaction mixture was diluted and deionized in a Centricon 30 microconcentrator (Amicon, Danvers, MA). After the amplified DNAs had been annealed with the 5' -labeled primers, nucleotide sequences were determined using a double-strand DNA Cycle Sequencing System (Gibco BRL).
Immunohistochemistry Immunohistochemical staining was performed on AMeX sections and frozen sections using an avidin-biotinylperoxidase 0022-202X/94/S07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. [19] . The monoclonal antibodies to p53 protein, pAb 1801, and D07 were obtained from Oncogene Science Inc. and Novocastra Laboratories Ltd., respectively. As positive controls, we used AMeX-fixed colon cancer tissuc sections. Negative controls were tissue sections that were incubated without the primary antibody.
RESULTS
Aberrations of the p53 Gene in SK The number of cases showing the immunohistochemical accumulation of the pS3 protein in the nuclei and/or an aberration of the pS3 gene by PCR-SSCP analysis was 10 of 27 SK (Table I and . Histologically, the bowenoid type was found to have mutations in a higher proportion of the cases, six of 9 (67%), and the atrophic type was found less frequently, in two of 11 cases (18%). Mutation was not detected in the five cases with a hypertrophic type lesion in the two cases with an acantholytic type lesion. The mutations were detected in exons 4, 6, 7, 8, and 10. Six of eight mutations were single-nucleotide missense mutations (Fig 2a) . Cases SK4, SK27, and SK33 showed the pS3 gene alteration, which lost the pS3 protein production because of nonsense mutation to stop codon, or by several base deletion (Fig 2b and Table I ). Base substitutions were three C to T and one T to C transitions, and one each T to G and C to A transversiollS. Dipyrimidine sites were involved in five cases. Three C to T substitutions occurred on the CpG methylation site (Table I) .
Immunohistochemical Analysis of the p53 Protein pS3 protein was stained in the nuclei of six of 27 SK (Table I and Fig 3) . Degree of positive nuclear staining varied by cases, but mostly more than half nuclei were stained. It was not detected in the neighboring normal epidermal cells and stromal cells.
Relationship Between p53 Gene Mutations and Nuclear Accumulation of p53 Protein The nuclear staining for pS3 protein and the presence of the pS3 gene alterations were not statistically associated (p < 0.08, Fisher's exact test). Association between the above two, however, became significant when only the missense mutation was accounted (p < 0.01, Fisher's exact test) (Table U) .
In SK2S, nuclear staining of the pS3 protein was negative, although the mutation from T to G was detected. This mutation was different from the common UV-specific substitution at dipyrirnidine site. The other three cases (SK33, SK27, and SK4) that were negative for nuclear staining had genetic changes to stop codon type (Table I) . In SKS and SK40, aberrations of the pS3 gene were not detected despite the positive nuclear staining of pS3 protein (Table I) .
DISCUSSION
We formerly reported the usefulness of immunohistochemical staining with anti-pS3 protein antibody [11] . An accumulation of the pS3 protein in the nuclei usually suggested the presence of a mutation in the gene, although pS3 accumulation was also observed shortly after UVB irradiation [20] . Campbell et of [21] reported that pS3 protein accumulated in the normal human skin as early as 24 h after UVB or UVC irradiation. In acute irradiation, pS3 protein may accumulate by direct binding to the damaged DNA or as a result of binding to heat-shock protein [22] . The gene sequence analysis in this study revealed that two cases had no mutation at all in the pS3 exons regardless of the positive pS3 staining. Four of six cases (67%) showed a significant coincidence between positive staining of pS3 protein and gene alteration. UV light may produce specific mutations, leaving a "signature" in the DNA. Mutations due to direct absorption of UV light by DNA are predominantly C to T transitions at dipyrimidine sites, including CC to IT a SK 7 double-base mutations [5 -8] . The appearance of C to T transitions exclusively at dipyrimidine site.s is also frequent by UV exposure. C~1a. nce ,:"ould dIctate that one m four would occur at a monopyrimidme slte [1] . Frequent C to T pattern of mutation was also reported bX .~ampbell et ~f [2~] i~ Bowen's disease. They suggested that the mltlal mutageruc lesIOn m the p53 gene in these lesions was dipyrimidine photoproducts induc~d b~ UV irradiation [23] .
Th~ spectrum of observed mutations m the case of solar keratosis was dIfferent from those observed by Brash et af [1] in SCC from sun-exposed skin. We found that five of eight cases (62.5%) of SK contained a mutation spectrum at dipyrimidine site specific for UV. Other uncommon UV specific mutations were one each of C to A and T to C nucleotide changes. These changes, however, were also found in the experimental UV irradiation [7, 8] . At least CC or GG sequence was involved in the two short deletion sites in our study (Table I) . Moles et al reported the similar change in BCC [4] . Methylation of CpGs in normal tissues Ulay increase the probability of mutations at such sites because of the ability of 5-methylcytosine to undergo deamination and result in thymine [24] . The p53 gene mutation in BCC at CG dinucleotides suggests that the particular mutation may be due to the 1 06-fold acceleration of cytosine deamination rate by cyclobutane dimers, occurring at 5-methylcytosine [25] . Nearly one third of the 280 human p53 tumor mutations were transitions at hot sporcodons with CpG sites (codons 175, 196,213, 248, 273, ~nd 282) .in human cancer of internal organs [26] ' In recent studIes, mutations at codon 248 were frequently observed in BCC and SCC by UV exposure [1, 3, 25] . In our series, only one of eight (12.5%) SK cases showed transitions at hot spot codon 248 in p5~ ~ene. Four cases were negative for p53 immunohistochemical stammg, although p53 gene aberrations were present. These were attri~uted t~ nonsense mutation to the stop codon or several base deletions. ZIegler et af [25] reported that the arginine changed to a st~p codon (c?don 342) in p53 gene in BCe. In the arginine codon bemg CGA m the p53 gene, these changes are likely to appear because of the ability of 5-methylcytosine to undergo deamination.
Sequencing of the p53 gene in mammals, amphibians, birds, and fish has revealed five highly conserved domains, four of which fall with~ e:,ons 5 t~ough 8 [26] . Ninety-eight percent of 280 base substItutIOn mutatIOns analyzed fell within a 600-base pair region of the p53 gene product (codons 110 to 307) [27] . In epithelial skin tuI?ors, . h~wever, about 30% of the aberrations of the p53 gene eXIsts witlun exons 4, 9, and 10 [1, 25] . It is better to examine entire domains of p53 gene for characterization of the UVB effects on this gene.
The use of immunohistochemical staining is a convenient and a useful tool for screening the p53 missense mutations. Combination of both i~unohistochemical staining and PCR-SSCP analysis, however, IS neces~ary because the non-production of p53 protein d~e to ge~e mutatIOn to stop codon was not negligible in p53 proteIn negative cases.
In the study of p53 knockout mice, Kemp et af [28] reported that lack.of p53 not only increases the rate of benign to malignant converSIOn, but also seems to drive further changes toward loss of diff~rentiation with increasing malignancy. Furthermore, they investigated that other genetic alterations, which may be facilitated by muta~t ras acting synergistically with lack of p53 gene, were respo~slble for ~riving malignant progression [28] . In our study, SK havmg alteration of p53 gene may possess ability to transform into SCC. In our preliminary work, by using the same SK sample in this s~d~, we found a point mutation of Ha-ras without any p53 mutation m one case (unpublished data).
A follow-up study of SK patients with p53 alteration is necessary 
